ZEPOSIA emb départ caps 4x0.23mg 3x0.46mg 7 pce
7680670460019
CH-67046
L04AE02
01.99.0.
Reimbursement limitations:
ZEPOSIA.01
Traitement de la sclérose en plaques (SEP) récurrente-rémittente. Première prescription par un spécialiste en neurologie …
1 / 3
google
Details
- Product number
- 6704601
- CPT
- -
- Packaging group
- 1
- Unit
- Kombipackung(en)
- Composition
- ozanimodum 0.23 mg ut ozanimodi hydrochloridum 0.25 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.187 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Articles (1)
Zeposia 0.23 mg, Hartkapseln
Hartkapseln
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.23 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.25 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 336.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2020
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 67046
- Drug name
- Zeposia, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AE02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/08/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZEPOSIA emb départ caps 4x0.23mg 3x0.46mg 7 pce
- Description (DE)
- ZEPOSIA Starterpack Kaps 4x0.23mg 3x0.46mg 7 Stk
- Market launch
- 11/08/2020
- Narcotic (BTM)
- No